Administered Prices: pt.26. Administred prices in the drug industry (antibiotics PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Administered Prices: pt.26. Administred prices in the drug industry (antibiotics PDF full book. Access full book title Administered Prices: pt.26. Administred prices in the drug industry (antibiotics by United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly. Download full books in PDF and EPUB format.
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Prices
Languages : en
Pages : 1210
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Prices
Languages : en
Pages : 1210
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Prices
Languages : en
Pages : 1602
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 390
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category : Antitrust law
Languages : en
Pages : 548
Get Book Here
Book Description
Examines the increasing economic concentration in the bread industry, bread retail price increases, and the status of competition between small independent bakeries and large bakery corporations.
Author: United States. Interagency Committee on New Therapies for Pain and Discomfort
Publisher:
ISBN:
Category : Hospice care
Languages : en
Pages : 272
Get Book Here
Book Description
Author: Patricia M. Danzon
Publisher: Oxford University Press
ISBN: 0199909261
Category : Business & Economics
Languages : en
Pages : 618
Get Book Here
Book Description
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summarizes the latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.
Author: Peter J. Neumann
Publisher: Oxford University Press
ISBN: 0190492937
Category : Business & Economics
Languages : en
Pages : 537
Get Book Here
Book Description
CEAs (cost-effectiveness analyses) are used by decision makers in the health sector to make enlightened evaluations and this book provides an in depth look at how to evaluate the evaluator. The book is aimed specifically at Public health specialists.
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Price regulation
Languages : en
Pages : 1214
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary
Publisher:
ISBN:
Category :
Languages : en
Pages : 294
Get Book Here
Book Description
![Study Paper[s] PDF](https://books.google.com/books/content/images/frontcover/CdSnvgEACAAJ?fife=w80-h100)
Author: United States. Congress. Joint Economic Committee
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1646
Get Book Here
Book Description
